Kevin J. McNamara
2017
In 2017, Kevin J. McNamara earned a total compensation of $7.9M as President and CEO at Chemed, a 21% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $22,572 |
|---|---|
| Non-Equity Incentive Plan | $2,247,732 |
| Option Awards | $2,544,850 |
| Salary | $1,094,990 |
| Stock Awards | $921,376 |
| Other | $1,102,997 |
| Total | $7,934,517 |
McNamara received $2.5M in option awards, accounting for 32% of the total pay in 2017.
McNamara also received $22.6K of change in pension value and nonqualified deferred compensation earnings, $2.2M in non-equity incentive plan, $1.1M in salary, $921.4K in stock awards and $1.1M in other compensation.
Rankings
In 2017, Kevin J. McNamara's compensation ranked 961st out of 14,666 executives tracked by ExecPay. In other words, McNamara earned more than 93.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 961 out of 14,666 | 93rd |
Division Services | 202 out of 2,426 | 92nd |
Major group Health Services | 11 out of 224 | 95th |
Industry group Home Health Care Services | 1 out of 31 | 97th |
Industry Home Health Care Services | 1 out of 31 | 97th |
Source: SEC filing on April 11, 2018.
McNamara's colleagues
We found four more compensation records of executives who worked with Kevin J. McNamara at Chemed in 2017.